Polymorphisms of the human IFNG gene noncoding regions

被引:68
作者
Bream, JH
Carrington, M
O'Toole, S
Dean, M
Gerrard, B
Shin, HD
Kosack, D
Modi, W
Young, HA [1 ]
Smith, MW
机构
[1] NCI, Expt Immunol Lab, Frederick, MD 21702 USA
[2] SAIC Frederick, Intramural Res Support Program, Frederick, MD 21702 USA
[3] NCI, Lab Genom Divers, Frederick, MD 21702 USA
关键词
interferon gamma; polymorphism; promoter; AIOS; 3 ' UTR;
D O I
10.1007/s002510050008
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Interferon gamma (IFN-gamma) is a multifunctional cytokine that is essential in the development of Th1 cells and in cellular responses to a variety of intracellular pathogens including human immunodeficiency virus (HIV-1). We screened genomic DNA samples from a predominately Caucasian male population of HIV-infected and healthy donors for polymorphisms in the human IFNG gene from -777 to +5608 by single-stranded conformational polymorphism. Surprisingly, the proximal promoter (-777 to transcription start) is invariant as no polymorphisms were found in over 100 samples tested. However, further screening revealed polymorphisms in other regions of the gene including a single base insertion in a poly-T tract in the first intron, three single base pair substitutions in the third intron, and another single base pair substitution in the 3' untranslated region (UTR), Electrophoretic mobility shift assay was used to investigate whether these variants have altered DNA-binding abilities, since intronic enhancer elements have been reported for the IFNG gene. Oligonucleotides constructed for two third intron variants showed no difference in DNA-binding abilities as compared with wild-type sequences. However, the 3'UTR variant showed the formation of unique DNA-binding complexes to radiolabeled oligonucleotide probes as compared with the wild-type sequence. The influence of a CA-repeat microsatellite on AIDS disease progression in HIV-1 seroconverters was tested by a Cox proportional hazards model. There is no evidence of an association between alleles and infection with HIV-1 or progression to AIDS. We report an invariant proximal human IFNG promoter and the existence of multiple intronic variants and a potentially functional 3'UTR polymorphism.
引用
收藏
页码:50 / 58
页数:9
相关论文
共 67 条
[31]   THE MULTICENTER AIDS COHORT STUDY - RATIONALE, ORGANIZATION, AND SELECTED CHARACTERISTICS OF THE PARTICIPANTS [J].
KASLOW, RA ;
OSTROW, DG ;
DETELS, R ;
PHAIR, JP ;
POLK, BF ;
RINALDO, CR .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1987, 126 (02) :310-318
[32]   Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies [J].
Khatri, VP ;
Fehniger, TA ;
Baiocchi, RA ;
Yu, F ;
Shah, MH ;
Schiller, DS ;
Gould, M ;
Gazzinelli, RT ;
Bernstein, ZP ;
Caligiuri, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (06) :1373-1378
[33]   A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation [J].
Kostrikis, LG ;
Huang, YX ;
Moore, JP ;
Wolinsky, SM ;
Zhang, LQ ;
Guo, Y ;
Deutsch, L ;
Phair, J ;
Neumann, AU ;
Ho, DD .
NATURE MEDICINE, 1998, 4 (03) :350-353
[34]   The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription [J].
Kroeger, KM ;
Carville, KS ;
Abraham, LJ .
MOLECULAR IMMUNOLOGY, 1997, 34 (05) :391-399
[35]   MECHANISMS OF VIRAL INHIBITION BY INTERFERONS [J].
LANDOLFO, S ;
GRIBAUDO, G ;
ANGERETTI, A ;
GARIGLIO, M .
PHARMACOLOGY & THERAPEUTICS, 1995, 65 (03) :415-442
[36]  
Lincoln S.E., 1991, PRIMER COMPUTER PROG
[37]   Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression [J].
Liu, HL ;
Chao, D ;
Nakayama, EE ;
Taguchi, H ;
Goto, M ;
Xin, XM ;
Takamatsu, J ;
Saito, H ;
Ishikawa, Y ;
Akaza, T ;
Juji, T ;
Takebe, Y ;
Ohishi, T ;
Fukutake, K ;
Maruyama, Y ;
Yashiki, SJ ;
Sonoda, S ;
Nakamura, T ;
Nagai, Y ;
Iwamoto, A ;
Shioda, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4581-4585
[38]   ABILITY OF HIV TO PROMOTE A T(H)1 TO T(H)0 SHIFT AND TO REPLICATE PREFERENTIALLY IN T(H)2 AND T(H)0 CELLS [J].
MAGGI, E ;
MAZZETTI, M ;
RAVINA, A ;
ANNUNZIATO, F ;
DECARLI, M ;
PICCINNI, MP ;
MANETTI, R ;
CARBONARI, M ;
PESCE, AM ;
DELPRETE, G ;
ROMAGNANI, S .
SCIENCE, 1994, 265 (5169) :244-248
[39]   Genetic acceleration of AIDS progression by a promoter variant of CCR5 [J].
Martin, MP ;
Dean, M ;
Smith, MW ;
Winkler, C ;
Gerrard, B ;
Michael, NL ;
Lee, B ;
Doms, RW ;
Margolick, J ;
Buchbinder, S ;
Goedert, JJ ;
O'Brien, TR ;
Hilgartner, MW ;
Vlahov, D ;
O'Brien, SJ ;
Carrington, M .
SCIENCE, 1998, 282 (5395) :1907-1911
[40]   CCR5 promoter polymorphism and HIV-1 disease progression [J].
McDermott, DH ;
Zimmerman, PA ;
Guignard, F ;
Kleeberger, CA ;
Leitman, SF ;
Murphy, PM .
LANCET, 1998, 352 (9131) :866-870